NEW YORK ( TheStreet
) -- CHANGE IN RATINGS
upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. Risk/reward is more attractive, following a 50% decline since July. $14 price target.
upgraded at Citi to Buy from Neutral, said Citigroup. The whiskey revolution in the U.S. will drive estimates and shares higher. Price target is now $76.
Bed Bath & Beyond
Bed Bath & Beyond was downgraded from outperform to perform at Oppenheimer.
downgraded to sell at TheStreet Ratings.
downgraded to hold at TheStreet Ratings.
Lululemon was downgraded to neutral from outperform. at Wedbush $75 price target. Quality erosion, rising competition and limited pent up demand, Wedbush said.
downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Company has anemic growth prospects. $52 price target.
upgraded at DA Davidson from Neutral to Buy, DA Davidson said. Company can deliver growth in multiple areas. $30 price target.
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call, as the stock is up 47% year-to-date.
was downgraded from outperform to perform at Oppenheimer.
was upgraded to buy at Jefferies. $39 price target. Company can achieve near-term prospects, Jefferies said.
downgraded at BMO to Market Perform from Outperform, BMO Capital Markets said. $46 price target. Slow growth of EA sales.
Sysco was downgraded from hold to sell at Cantor Fitzgerald said. Valuation call.
downgraded at Oppenheimer from Outperform, to Perform, Oppenheimer said. Growth appears to be decelerating.
upgraded at Oppenheimer from Perform to Outperform, Oppenheimer said. $125 price target. Company can continue to deliver strong unit growth.
STOCK COMMENTS / EPS CHANGES
American Eagle Outfitters
numbers cut at Janney. Target now seen reaching $21, Janney Capital Markets said. Estimates also lowered through 2014 as promotions deepen in April. Buy raitng.
American International Group
numbers raised at Sterne Agee. Shares of AIG now seen reaching $46, Sterne Agee said. Estimates also increased on strong results and improving expenses. Neutral rating.
added to Conviction Buy List at Goldman. Company appears to be firing on all cylinders.
price target and estimates increased at UBS. CBI earnings estimates were increased to reflect the Shaw acquisition, said UBS. Bookings outlook may be revisited. Price target is now $61.
Fluor estimates reduced at UBS to reflect slightly lower revs from I&I given mining headwinds, said UBS.
price target and estimates raised at Citi. The core business has a lot of momentum while there are still synergy opportunities based on M&A. Price target is now $89.
numbers raised at BMO. Shares of KRFT now seen reaching $56, BMO Capital Markets said. Estimates also increased on better than expected top line growth. Outperform rating.